Last edition
News about
Biocon Signs Exclusive Licensing and Supply Deal with Biomm for Drug Commercialization
Biocon Limited has signed an exclusive licensing and supply agreement with Biomm to commercialize its vertically integrated drug product, Semaglutide (gOzempic).
Ferring Signs Commercial Gene Therapy Manufacturing Deal with SK pharmteco
Ferring Pharmaceuticals has inked an agreement with SK pharmteco to scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical gene therapy Adstiladrin.
OrthoIndy Introduces Augmented Reality into Surgical Procedures
OrthoIndy has announced a monumental step forward in surgical innovation by introducing augmented reality (AR) into surgical procedures.
HealthSignals Secures Telehealth Agreement with Premier
Committed to enhancing the quality of care, HealthSignals provides facilities with essential tools that prioritize security, reliability, and effective communication and collaboration for telehealth and telemedicine applications.
X-Therma's XT-Thrive Receives FDA Acceptance for Key Drug Master File
This milestone covers the Chemistry, Manufacturing, and Controls (CMC) for XT-Thrive®, a revolutionary cryopreservation solution enabling non-toxic preservation for life-saving regenerative medicines.
Recce Pharmaceuticals Hits Milestone with RECCE 327 Batch Completion Under GMP
The company's lead candidate, R327, marks a new era in synthetic anti-infectives, with the patented manufacturing process now yielding 5,000 GMP doses per week.
Emerson Introduces DeltaV Workflow Management to Simplify Pharmaceutical Development
Emerson has released DeltaV Workflow Management, a next-generation software designed for life sciences companies in early-stage development.
Merck Unveils First All-in-One Genetic Stability Assay to Boost Biosafety Testing
Merck has unveiled the first all-in-one, validated genetic stability assay of its kind.
Emirates SkyCargo Joins Pharma.Aero to Boost Pharma Logistics Standards
Pharma.Aero has announced the joining of Emirates SkyCargo to its alliance.
Telomir Pharmaceuticals Launches Pre-Clinical Data on Age-Reversal Drug Telomir-1
Telomir Pharmaceuticals, Inc. has summarized its presentation of compelling pre-clinical data on Telomir-1 at a high-profile event.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy